Add BrightSurf on Google Email

Science News for March 2, 2008


Nanomedicine system engineered to enhance therapeutic effects of injectable drugs

Researchers developed a multistage delivery system to improve injectable drug efficacy, targeting diseased cells and releasing therapeutics in a controlled manner. The system uses mesoporous silicon particles to circumvent biobarriers and deliver diagnostic agents or therapeutic agents.

SourceUniversity of Texas Health Science Center at Houston·JournalNature Nanotechnology·DateMar 2, 2008

Ski tourism stressing capercaillie

Researchers found ski tourism raises stress levels among capercaillie, harming their fitness and ability to breed. The study recommends keeping forests inhabited by the birds free from tourism infrastructure.

SourceWiley·JournalJournal of Applied Ecology·DateMar 2, 2008

HIV breakthrough: Researchers identify protein that fights immunodeficiency

A Canadian-US research team has solved a major genetic mystery: how a protein in some people's DNA guards against killer immune diseases like HIV. The discovery of FOX03a offers promise for HIV vaccine development and treatments for other immune diseases, such as cancer and rheumatoid arthritis.

SourceUniversity of Montreal·JournalNature Medicine·DateMar 2, 2008
SAMSUNG T9 Portable SSD 2TB

SAMSUNG T9 Portable SSD 2TB transfers large imagery and model outputs quickly between field laptops, lab workstations, and secure archives.

USC researchers discover novel way to develop tumor vaccines

Researchers at USC have identified A20 as an antigen presentation attenuator that prevents excessive inflammation of dendritic cells. By inhibiting A20, they found a new way to overcome regulatory T cell-mediated suppression and trigger strong antitumor immunity.

SourceUniversity of Southern California·JournalNature Medicine·DateMar 2, 2008

Scientists uncover further steps leading to celiac disease

Researchers have identified an additional seven gene regions associated with coeliac disease, revealing a connection to type 1 diabetes. The study also highlights the importance of immune response genes in the development of coeliac disease, providing new insights into its causes and potential treatments.

SourceQueen Mary University of London·JournalNature Genetics·DateMar 2, 2008